Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 6pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5639787: Therapeutic method for the treatment of cancer
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
6 pages

 
Inventor: Riordan, Neil H.; Wichita, KS
Riordan, Hugh D.; Wichita, KS

Assignee: The Center for the Improvement of Human Functioning Int'l, Inc., Wichita, KS
other patents from THE CENTER FOR THE IMPROVEMENT OF HUMAN FUNCTIONING INT'L, INC. (731044) (approx. 7)
 News, Profiles, Stocks and More about this company

Published / Filed: 1997-06-17 / 1995-02-28

Application Number: US1995000397663

IPC Code: Advanced: A61K 9/00; A61K 31/375; A61K 33/00; A61K 33/26; A61K 33/34; A61K 33/40; A61K 47/36;
Core: more...
IPC-7: A01N 43/08;

ECLA Code: A61K9/00M5; A61K31/375; A61K31/375+M; A61K33/00+M; A61K33/26+M; A61K33/34+M; A61K33/40+M; A61K47/36;

U.S. Class: Current: 514/474; 514/449;
Original: 514/474; 514/449;

Field of Search: 514/474,449

Priority Number:
1995-02-28  US1995000397663

Abstract:     A method of treating cancer in a patient by raising and maintaining the concentration of ascorbic acid, or ascorbate, in the patient's plasma to at least the level expected to be toxic to an in vitro culture of cells of the type of cancer being treated, the required plasma ascorbate levels being achieved and maintained using long term intravenous infusions of large amounts of ascorbate, with or without ascorbate cytotoxicity effectiveness enhancing or tumor site delivery and absorption enhancing agents.

Attorney, Agent or Firm: Lee, Philip J. ;

Primary / Asst. Examiners: Nutter, Nathan M.; Williamson, Michael A.

INPADOC Legal Status: Show legal status actions

Family: None

First Claim:
Show all 32 claims
What is claimed is:     1. A method of treating cancer in patients consisting essentially of the step of administering to the patient, by intravenous infusion, an anti-cancer effective dose of ascorbic acid or a pharmaceutically acceptable salt thereof.

Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 10 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (10)   |   Backward references (5)   |   Citation Link

Buy
PDF
Patent  Pub.Date  Inventor Assignee   Title
Buy PDF- 6pp US5032610  1991-07 Borretzen et al.  Norsk Hydro AS Activity against carcinoma and method for the treatment of carcinoma
Buy PDF- 6pp US5036103  1991-07 Kochi   Method of treating cancer cells in humans
Buy PDF- 11pp US5117972  1992-05 Ohwishi  Klearfold, Inc. Container
Buy PDF- 5pp US5130145  1992-07 Oftebro et al.  Norsk Hydro A.S. Pharmaceutical compositions with anit-cancer activity and method for the treatment of cancer
Buy PDF- 6pp US5135948  1992-08 Borretzen et al.  Norsk Hydro a.s. Pharmaceutical compositions with anti-cancer activity against carcinoma and method for the treatment of carcinoma
       
Foreign References: None

Other Abstract Info: DERABS C97-340543 DERC97-340543

Other References:
  • Riordan, N. et al; Intravenous Ascorbate as a tumor cytotoxic chemotherapic agent, Mar. 1995 Journal of Medical Hypothesis.


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help